Indication

Exposure keratoconjunctivitis

Exposure keratoconjunctivitis is an inflammatory condition of the ocular surface involving both the cornea and the conjunctiva, primarily triggered by chronic or recurrent ocular surface desiccation. Read more about Exposure keratoconjunctivitis

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Exposure keratoconjunctivitis therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Exposure keratoconjunctivitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Exposure keratoconjunctivitis.

Exposure keratoconjunctivitis is an inflammatory condition of the ocular surface involving both the cornea and the conjunctiva, primarily triggered by chronic or recurrent ocular surface desiccation.

It arises in individuals experiencing incomplete eyelid closure or impaired blink dynamics, such as patients with lagophthalmos, facial nerve palsy, severe proptosis, eyelid malpositions, or diminished consciousness.

Pathophysiologically, the failure of complete eyelid apposition disrupts the preocular tear film and accelerates evaporation, leading to hyperosmolarity and mechanical shear.

This process results in conjunctival hyperemia, punctate epithelial erosions predominantly across the inferior palpebral fissure, ocular irritation, and, if left unaddressed, risks of progressive corneal ulceration and scarring.

Personalize your experience

Follow Exposure keratoconjunctivitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it